These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 35349717)

  • 21. Assessing the Impact of PCSK9 and HMGCR Inhibition on Liver Function: Drug-Target Mendelian Randomization Analyses in Four Ancestries.
    Rosoff DB; Bell AS; Wagner J; Mavromatis LA; Hamandi A; Park L; Jung J; Lohoff FW
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):29-40. PubMed ID: 37703945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization.
    Wu T; Ye L; Wang S; Huang J; Zhang J
    Front Pharmacol; 2023; 14():1258018. PubMed ID: 37964871
    [No Abstract]   [Full Text] [Related]  

  • 23. Association between Lipid-Lowering Drugs and Traumatic Subdural Hemorrhage: A Mendelian Randomization Study.
    Chen K; Li H; Chen Y; Huang H; Wei L
    J Integr Neurosci; 2024 Apr; 23(4):76. PubMed ID: 38682216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis.
    Chen H; Zhou X; Hu J; Li S; Wang Z; Zhu T; Cheng H; Zhang G
    Lipids Health Dis; 2023 Dec; 22(1):220. PubMed ID: 38082436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function.
    Rosoff DB; Bell AS; Jung J; Wagner J; Mavromatis LA; Lohoff FW
    J Am Coll Cardiol; 2022 Aug; 80(7):653-662. PubMed ID: 35953131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations.
    Ardissino M; Slob EAW; Reddy RK; Morley AP; Schuermans A; Hill P; Williamson C; Honigberg MC; de Marvao A; Ng FS
    Eur J Prev Cardiol; 2024 Jun; 31(8):955-965. PubMed ID: 38294056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
    Li J; Yang Z; Wang T; Li M; Wu X; Fu X; Yang C; Li Y; Wang X; Lan Z; Li M; Chen S
    BMC Cancer; 2024 May; 24(1):667. PubMed ID: 38822303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Target Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Atrial Fibrillation.
    Li F; Mei Y; Wu Q; Wu X
    Cardiology; 2024; 149(5):495-501. PubMed ID: 38531334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study.
    Cai G; Liu J; Cai M; Shao L
    Lipids Health Dis; 2024 Aug; 23(1):237. PubMed ID: 39090671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of lipid-lowering drugs with osteoarthritis outcomes from a drug-target Mendelian randomization study.
    Ma W; Chen H; Zhang Z; Xiong Y
    PLoS One; 2024; 19(2):e0293960. PubMed ID: 38416763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causal effects of lipid-lowering drugs on skin diseases: a two-sample Mendelian randomization study.
    Liu Y; Liu H; Bian Q
    Front Med (Lausanne); 2024; 11():1396036. PubMed ID: 39386745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study.
    Ji X; Guo HY; Han M; Peng H; Yuan H
    Int J Rheum Dis; 2024 Apr; 27(4):e15106. PubMed ID: 38568054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study.
    Tan Z; Hong J; Sun A; Ding M; Shen J
    Front Endocrinol (Lausanne); 2023; 14():1301163. PubMed ID: 38107516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization Study.
    Bell AS; Rosoff DB; Mavromatis LA; Jung J; Wagner J; Lohoff FW
    J Am Heart Assoc; 2022 Nov; 11(21):e026122. PubMed ID: 36285785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study.
    Liu L; Sheng C; Lyu Z; Dai H; Chen K
    Front Nutr; 2021; 8():755834. PubMed ID: 34712689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causal effects of lipid-lowering drugs on inflammatory skin diseases: Evidence from drug target Mendelian randomisation.
    Zang C; Li J; Zhang Y; Deng W; Mao M; Zhu W; Chen W
    Exp Dermatol; 2024 Sep; 33(9):e15157. PubMed ID: 39227185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically proxied PCSK9 inhibition is associated with reduced psoriatic arthritis risk.
    Li J; Li J; Lin C; Zhou J; Wang J; Wang F; Li H; Zhou Z
    Inflamm Res; 2024 Mar; 73(3):475-484. PubMed ID: 38341813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization.
    Hu X; Zhang P; Gao Y; Ding WW; Cheng XE; Shi QQ; Li S; Zhu YY; Pan HF; Wang P
    Lipids Health Dis; 2024 Jun; 23(1):193. PubMed ID: 38909219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.
    Ding W; Chen L; Xia J; Pei B; Song B; Li X
    Medicine (Baltimore); 2024 May; 103(18):e38010. PubMed ID: 38701318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.